Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives
Christopher E. Bayne(Carilion Clinic), Brian F. Chapin(The University of Texas MD Anderson Cancer Center), Prasanna Sooriakumaran(University College London Hospitals NHS Foundation Trust), Giacomo Novara(University of Padua), Stephen B. Williams(Cedars-Sinai Medical Center), Francesco Montorsi(Vita-Salute San Raffaele University), Martin Gleave(University of British Columbia), Marc C. Smaldone(Fox Chase Cancer Center), Peter Wiklund(Unknown), Matthew R. Cooperberg(University of California, San Francisco), Markus Graefen(Eppendorf (Germany))
Cited by 92
Related Papers
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592